ConductScience.org, home

Paper2015114

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

Clements GJ and 9 others. AIDS Res Hum Retroviruses, 1991. Cited by 257 papers, by iCite.

Cite this record

ConductScience Library. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? Papers, record 2015114. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2015114

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
PubMed
Journal
AIDS Res Hum Retroviruses
PubMed
Year
1991
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
257
iCite
Relative citation ratio, by iCite
6.15
iCite
Revised in PubMed
2017-11-16
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clements GJG J
2Price-Jones MJM J
3Stephens PEP E
4Sutton CC
5Schulz TFT F
6Clapham PRP R
7McKeating JAJ A
8McClure MOM O
9Thomson SS
10Marsh MM

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV Envelope Protein gp120Major topic
HIV-1Major topic
HIV-2Major topic
Amino Acid Sequence
Animals
Antibodies, Monoclonal
CD4 Antigens
Cathepsin E
Cathepsins
Cell Line
Cricetinae
Electrophoresis, Polyacrylamide Gel
Endopeptidases
Humans
Insecta
Membrane Fusion
Molecular Sequence Data
Neutralization Tests
Peptide Hydrolases
Thrombin

Source PubMed

Download CSV of topics

Cited by95

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.

PMIDTitleJournalYearIn PapersSource
41295975Characterization of full-length and cytoplasmic tail-truncated envelope glycoproteins incorporated into human immunodeficiency virus (HIV-1) virions and virus-like particles.J Virol2025https://conductscience.org/library/papers/41295975PubMed
33801906Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.Vaccines (Basel)2021https://conductscience.org/library/papers/33801906PubMed
32470085Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.PLoS One2020https://conductscience.org/library/papers/32470085PubMed
31087560Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.Biotechnol Bioeng2019https://conductscience.org/library/papers/31087560PubMed
29689099Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.PLoS One2018https://conductscience.org/library/papers/29689099PubMed
28878072High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.J Virol2017https://conductscience.org/library/papers/28878072PubMed
28133806Native-like Env trimers as a platform for HIV-1 vaccine design.Immunol Rev2017https://conductscience.org/library/papers/28133806PubMed
26458166Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols.ACS Chem Biol2015https://conductscience.org/library/papers/26458166PubMed
25911103The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.J Biol Chem2015https://conductscience.org/library/papers/25911103PubMed
25589637A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.J Virol2015https://conductscience.org/library/papers/25589637PubMed
24767177Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.Retrovirology2014https://conductscience.org/library/papers/24767177PubMed
23304142Retrovirus entry by endocytosis and cathepsin proteases.Adv Virol2012https://conductscience.org/library/papers/23304142PubMed
22085380Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).J Med Chem2012https://conductscience.org/library/papers/22085380PubMed
21565895Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.Exp Biol Med (Maywood)2011https://conductscience.org/library/papers/21565895PubMed
20825246Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.Biochemistry2010https://conductscience.org/library/papers/20825246PubMed
17901336Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.Science2007https://conductscience.org/library/papers/17901336PubMed
17301129
Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.
J Virol2007https://conductscience.org/library/papers/17301129PubMed
16571818Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.J Virol2006https://conductscience.org/library/papers/16571818PubMed
11861826Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.J Virol2002https://conductscience.org/library/papers/11861826PubMed
10623764A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line.J Virol2000https://conductscience.org/library/papers/10623764PubMed

See all 95 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CTSE1510PubTator's text mininghttps://conductscience.org/library/genes/1510NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
SCD579966PubTator's text mininghttps://conductscience.org/library/genes/79966NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2015114

GET https://conductscience.org/api/papers/v1/2015114/cited_by?page=2